BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20001766)

  • 1. Bone and joint involvement in Fabry disease.
    Sacre K; Lidove O; Giroux Leprieur B; Ouali N; Laganier J; Caillaud C; Papo T
    Scand J Rheumatol; 2010 Mar; 39(2):171-4. PubMed ID: 20001766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
    Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
    Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.
    Jørgensen NR; Schwarz P; Holme I; Henriksen BM; Petersen LJ; Backer V
    Respir Med; 2007 Jan; 101(1):177-85. PubMed ID: 16677808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral femoral head and distal tibial osteonecrosis in a patient with Fabry disease.
    Lien YH; Lai LW
    Am J Orthop (Belle Mead NJ); 2005 Apr; 34(4):192-4. PubMed ID: 15913175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarkable variability in renal disease in a large Slovenian family with Fabry disease.
    Verovnik F; Benko D; Vujkovac B; Linthorst GE
    Eur J Hum Genet; 2004 Aug; 12(8):678-81. PubMed ID: 15162124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R; Olea T
    Nefrologia; 2002; 22(6):540-6. PubMed ID: 12516287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiari type I malformation in four unrelated patients affected with Fabry disease.
    Germain DP; Benistan K; Halimi P
    Eur J Med Genet; 2006; 49(5):419-25. PubMed ID: 16510324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
    Bryant ML; Worthington MA; Parsons K
    Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fabry disease: data from four families].
    Slee PH; van Boven LJ; Slee DS
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2412-5. PubMed ID: 11145098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
    Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
    Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.
    Merta M; Reiterova J; Ledvinova J; Poupetová H; Dobrovolny R; Rysavá R; Maixnerová D; Bultas J; Motán J; Slivkova J; Sobotova D; Smrzova J; Tesar V
    Nephrol Dial Transplant; 2007 Jan; 22(1):179-86. PubMed ID: 17040996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdisciplinary approach towards female patients with Fabry disease.
    Weidemann F; Niemann M; Sommer C; Beer M; Breunig F; Wanner C
    Eur J Clin Invest; 2012 Apr; 42(4):455-62. PubMed ID: 22049975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hearing status in 12 female and 15 male Japanese Fabry patients.
    Sakurai Y; Kojima H; Shiwa M; Ohashi T; Eto Y; Moriyama H
    Auris Nasus Larynx; 2009 Dec; 36(6):627-32. PubMed ID: 19261412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile osteoporosis: recognizing the risk.
    Key LL; Ries W; Madyastha P; Reed F
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():683-6. PubMed ID: 12795371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
    Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
    Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.